International Journal of Life Science Study (ISSN: 2329-6119, eISSN: 2329-6100) is an open access and peer reviewed International Journal which is dedicated to publish high-quality articles dedicated to all aspects of the latest outstanding developments in the field of Life Science.
Its scope encompasses but not limited to, the following scope:
Manuscripts should present novel preclinical findings addressing questions of biological significance to human disease. Studies that fail to do so may be rejected without review. Quantitative conclusions must be based on truly quantitative methods. Life Sciences does not publish work on the actions of biological extracts of unknown chemical composition. Compounds studied must be of known chemical structure and concentration. The study must be reproducible; materials used must be available to other researchers so they can repeat the experiment. Clinical studies may be considered if they expand understanding of mechanism, but the journal does not encourage clinical trial reports.
Four common reasons for rejection include: out of scope (the manuscript does not conform to the goal of identification of mechanisms related to therapy for human disease); too preliminary (manuscript is based on a limited amount of experimental data diminishing significance); lack of novelty (manuscript is well done but does not address a significant question); unidentified structure (actions of biological extracts of unknown chemical composition).
Peer Review Policy
All peer review is single blind and submission is online via Editorial Manager.
Article publishing charge
Authors will pay $399 only from 2021 onwards.
Submission charges
There are no submission charges for this journal.